ABSTRACT
WAYS IN WHICH TO SUBMIT DRUG SUBSTANCE INFORMATION Where a major pharmaceutical company has developed its own new drug substance and will itself manufacture batches for inclusion in batches of new drug product for world-wide marketing after registration approvals, all of the documentation in Modules 3.2.S.1 to 3.2.S.7 can be included directly in the CTD Module 3.2.S documentation.
